181 related articles for article (PubMed ID: 30760223)
21. Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia.
Paik SH; Yoon JS; Ryu HH; Lee JY; Shin CY; Min KH; Jo SJ; Kim KH; Kwon O
Exp Dermatol; 2013 Jul; 22(7):496-9. PubMed ID: 23800066
[TBL] [Abstract][Full Text] [Related]
22. Permanent alopecia following chemotherapy and bone marrow transplantation.
Tran D; Sinclair RD; Schwarer AP; Chow CW
Australas J Dermatol; 2000 May; 41(2):106-8. PubMed ID: 10812705
[TBL] [Abstract][Full Text] [Related]
23. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
Maurer M; Handjiski B; Paus R
Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
[TBL] [Abstract][Full Text] [Related]
24. Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA).
Wikramanayake TC; Villasante AC; Mauro LM; Nouri K; Schachner LA; Perez CI; Jimenez JJ
Lasers Med Sci; 2013 May; 28(3):701-6. PubMed ID: 22696077
[TBL] [Abstract][Full Text] [Related]
25. Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia.
Yoneda K; Fujii M; Imaoka A; Kobayashi R; Hayashi R; Yoshida Y; Kohno T; Tsuji T
Support Care Cancer; 2021 Oct; 29(10):6127-6134. PubMed ID: 33797584
[TBL] [Abstract][Full Text] [Related]
26. Modeling Chemotherapy-Induced Hair Loss: From Experimental Propositions toward Clinical Reality.
Botchkarev VA; Sharov AA
J Invest Dermatol; 2016 Mar; 136(3):557-559. PubMed ID: 26902124
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chemotherapy-induced alopecia.
Yeager CE; Olsen EA
Dermatol Ther; 2011; 24(4):432-42. PubMed ID: 21910801
[TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of doxorubicin-induced alopecia in mice by dietary administration of L-cystine and vitamin B6.
D'Agostini F; Fiallo P; Ghio M; De Flora S
Arch Dermatol Res; 2013 Jan; 305(1):25-34. PubMed ID: 22699427
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial of minoxidil in chemotherapy-induced alopecia.
Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of cooling therapy and α-lipoic acid derivative against chemotherapy-induced alopecia in an animal model.
Aiba T; Kono Y; Etoh T; Kawano Y; Oshima Y; Inomata M
Cancer Sci; 2023 Mar; 114(3):1007-1014. PubMed ID: 36337052
[TBL] [Abstract][Full Text] [Related]
31. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-induced irreversible alopecia in early breast cancer patients.
Kim GM; Kim S; Park HS; Kim JY; Nam S; Park S; Kim SI; Kim D; Sohn J
Breast Cancer Res Treat; 2017 Jun; 163(3):527-533. PubMed ID: 28324267
[TBL] [Abstract][Full Text] [Related]
33. p53 is essential for chemotherapy-induced hair loss.
Botchkarev VA; Komarova EA; Siebenhaar F; Botchkareva NV; Komarov PG; Maurer M; Gilchrest BA; Gudkov AV
Cancer Res; 2000 Sep; 60(18):5002-6. PubMed ID: 11016618
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
[TBL] [Abstract][Full Text] [Related]
35. Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia.
Imanishi H; Tsuruta D; Tateishi C; Sugawara K; Paus R; Tsuji T; Ishii M; Ikeda K; Kunimoto H; Nakajima K; Jones JC; Kobayashi H
J Dermatol Sci; 2010 Apr; 58(1):43-54. PubMed ID: 20211547
[TBL] [Abstract][Full Text] [Related]
36. Treatment with ImuVert/N-acetylcysteine protects rats from cyclophosphamide/cytarabine-induced alopecia.
Jiménez JJ; Huang HS; Yunis AA
Cancer Invest; 1992; 10(4):271-6. PubMed ID: 1628226
[TBL] [Abstract][Full Text] [Related]
37. Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopecia.
Nasr Z; Dow LE; Paquet M; Chu J; Ravindar K; Somaiah R; Deslongchamps P; Porco JA; Lowe SW; Pelletier J
BMC Pharmacol Toxicol; 2013 Nov; 14():58. PubMed ID: 24219888
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics of chemotherapy-induced alopecia in childhood.
Choi M; Kim MS; Park SY; Park GH; Jo SJ; Cho KH; Lee JW; Park KD; Shin HY; Kang HJ; Kwon O
J Am Acad Dermatol; 2014 Mar; 70(3):499-505. PubMed ID: 24355411
[TBL] [Abstract][Full Text] [Related]
39. Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain.
Katikaneni R; Ponnapakkam T; Suda H; Miyata S; Sakon J; Matsushita O; Gensure RC
Int J Cancer; 2012 Sep; 131(5):E813-21. PubMed ID: 22130912
[TBL] [Abstract][Full Text] [Related]
40. Occurrence and severity of alopecia in patients on combination chemotherapy.
Pai GS; Vimala AM; Dinesh M
Indian J Cancer; 2000; 37(2-3):95-104. PubMed ID: 11876617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
